Urgent need for pragmatic trial platforms in severe asthma

Lancet Respir Med. 2018 Aug;6(8):581-583. doi: 10.1016/S2213-2600(18)30291-1.
No abstract available

MeSH terms

  • Anti-Asthmatic Agents / economics
  • Anti-Asthmatic Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Asthma* / drug therapy
  • Asthma* / economics
  • Biological Products / economics
  • Biological Products / therapeutic use
  • Drug Development / standards
  • Humans
  • Pragmatic Clinical Trials as Topic*
  • Severity of Illness Index

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal
  • Biological Products